NKNancy Mizue Kokitsu-Nakata

Nancy Mizue Kokitsu-Nakata

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nancy Mizue Kokitsu-Nakata has a total of 177 co-authors. Here are the top co-authors by number of shared publications:

  • Maria Leine Guion-Almeida

    Department of Clinical Genetics, Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo, Bauru 17012-900, Brazil

    6 shared publications
  • Roseli Maria Zechi‐Ceide

    Department of Clinical Genetics Hospital for Rehabilitation of Craniofacial Anomalies (HRAC), University of São Paulo (USP) Bauru Brazil

    6 shared publications
  • Maria Leine Guion‐Almeida

    Department of Clinical Genetics, Hospital for Rehabilitation of Craniofacial Anomalies University of São Paulo (HRCA‐USP) Bauru Brazil

    5 shared publications
  • Siulan Vendramini‐Pittoli

    Department of Clinical Genetics, Hospital for Rehabilitation of Craniofacial Anomalies University of São Paulo Bauru São Paulo Brazil

    5 shared publications
  • Christopher T. Gordon

    Laboratory of Embryology and Genetics of Human Malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Université Paris Cité, Paris, 75015, France

    4 shared publications
  • Jeanne Amiel

    Service de Génétique, INSERM U781, Hôpital Necker-Enfants Malades, Institut Imagine, University Sorbonne-Paris-Cité, Paris, France

    4 shared publications

Latest Publications

  • Open Access

    Clinical Genetic Aspects

    by Nancy Mizue Kokitsu-Nakata, Luiza Do Amaral Virmond, Henrique Regonaschi Serigatto

    This chapter discusses the clinical features of individuals with Apert syndrome and shares our experience with children diagnosed with this condition who are treated at a specialized hospital, recognized as a national and international referral center, located in the interior of the state of São Paulo, Brazil. Individuals with Apert syndrome typically require a series of complex surgical interventions to treat craniofacial and limb anomalies, as well as ongoing monitoring and treatment for associated functional impairments, including respiratory, cognitive, and developmental difficulties. Apert syndrome requires a multidisciplinary approach to treatment, involving specialists in neurosurgery, plastic surgery, genetics, ophthalmology, otolaryngology, orthopedics, orthodontics, psychology, and speech therapy. In this context, we performed an analysis of the phenotypic characterization of Apert syndrome based on literature, as well as the clinical variability of craniofacial and limb characteristics observed in 99 individuals treated at our institution. The phenotypic variability highlights the challenges associated with diagnosis and clinical management in a public health context, underlining the importance of developing individualized clinical protocols. These protocols should include expanding access to genetic testing, ensuring optimized care, and providing appropriate genetic counseling.

  • Unusual Association of Orofacial Cleft and Finger-Like Skin Appendages With or Without Constriction Rings: A Disorganization-Like Phenotype?

    by Henrique Regonaschi Serigatto, Siulan Vendramini-Pittoli, Priscila Padilha Moura, Luiza Virmond, Vinicius Contrucci Dantas Segarra, José Humberto da Cunha, Carla Rosenberg, Roseli Maria Zechi-Ceide, Nancy Mizue Kokitsu-Nakata

    The mouse disorganization (Ds) was described in mutant mice with multiple congenital anomalies arising from the 3 germinative layers. The human homologue of Ds was proposed in a case presenting multiple congenital anomalies associated with the unique feature of a finger-like skin appendage. Since then, several cases have been reported suggesting the occurrence of a disorganization-like (Ds-like) phenotype in humans. Here, we report a case series of 7 patients presenting with the association of orofacial clefts and finger-like skin appendages. These cases, despite the similarities with Ds and amniotic band sequence, may represent a distinct condition within the spectrum of Ds-like, as other cases previously reported in the literature.

  • Low‐pass whole genome sequencing as a cost‐effective alternative to chromosomal microarray analysis for low‐ and middle‐income countries

    by Patricia C. Mazzonetto, Darine Villela, Ana C. V. Krepischi, Paulo M. Pierry, Adriano Bonaldi, Luiz Gustavo D. Almeida, Marcelo G. Paula, Matheus Carvalho Bürger, Ana Gabriela de Oliveira, Gustavo G. G. Fonseca, et al.

    Low‐pass whole genome sequencing (LP‐WGS) has been applied as alternative method to detect copy number variants (CNVs) in the clinical setting. Compared with chromosomal microarray analysis (CMA), the sequencing‐based approach provides a similar resolution of CNV detection at a lower cost. In this study, we assessed the efficiency and reliability of LP‐WGS as a more affordable alternative to CMA. A total of 1363 patients with unexplained neurodevelopmental delay/intellectual disability, autism spectrum disorders, and/or multiple congenital anomalies were enrolled. Those patients were referred from 15 nonprofit organizations and university centers located in different states in Brazil. The analysis of LP‐WGS at 1x coverage (>50kb) revealed a positive testing result in 22% of the cases (304/1363), in which 219 and 85 correspond to pathogenic/likely pathogenic (P/LP) CNVs and variants of uncertain significance (VUS), respectively. The 16% (219/1363) diagnostic yield observed in our cohort is comparable to the 15%–20% reported for CMA in the literature. The use of commercial software, as demonstrated in this study, simplifies the implementation of the test in clinical settings. Particularly for countries like Brazil, where the cost of CMA presents a substantial barrier to most of the population, LP‐WGS emerges as a cost‐effective alternative for investigating copy number changes in cytogenetics.


  • Hemiarhinia caused by a missense variation in SMCHD1: A mild phenotype in the clinical spectrum of Bosma arhinia microphthalmia syndrome

    by Nancy Mizue Kokitsu‐Nakata, Vinicius Contrucci Dantas Segarra, Cristiano Tonello, Michele Madeira Brandão, Nivaldo Alonso, Roseli Maria Zechi‐Ceide

    Bosma arhinia microphthalmia syndrome (BAMS, OMIM #603457) is a rare autosomal dominant disorder caused by heterozygous variation in the SMCHD1 gene on chromosome 18p11. Clinically, it is characterized by microphthalmia, absence or hypoplasia of nose, choanal atresia, anosmia, palatal abnormalities, hypogonadotropic hypogonadism, and cryptorchidism. Here we report a Brazilian patient with a likely pathogenic variation in SMCHD1 gene (c.1418A>T; p.Glu473Val) presenting hemiarhinia associated with short stature and hypogonadotropic hypogonadism. Due to the clinical variability of BAMS, we considered that hemiarhinia, without microphthalmia, in the present case, can be considered a mild form of BAMS and could be considered for screening of SMCHD1 gene variation.


  • Identification of a de novo PUF60 variant associated with craniofacial microsomia

    by Takuya Ogawa, Jingyi Xue, Long Guo, Maristela Sayuri Inoue‐Arai, Siulan Vendramini‐Pittoli, Roseli Maria Zechi‐Ceide, Rosana Maria Candido‐Souza, Cristiano Tonello, Michele Madeira Brandão, Terumi Okada Ozawa, et al.

    Craniofacial microsomia (CFM), also known as the oculo‐auriculo‐vertebral spectrum, is a congenital disorder characterized by hypoplasia of the mandible and external ear due to tissue malformations originating from the first and second branchial arches. However, distinguishing it from other syndromes of branchial arch abnormalities is difficult, and causal variants remain unidentified in many cases. In this report, we performed an exome sequencing analysis of a Brazilian family with CFM. The proband was a 12‐month‐old boy with clinical findings consistent with the diagnostic criteria for CFM, including unilateral mandibular hypoplasia, microtia, and external auditory canal abnormalities. A heterozygous de novo nonsense variant (c.713C>G, p.S238*) in PUF60 was identified, which was predicted to be pathogenic in silico. PUF60 has been reported as a causal gene in Verheij syndrome, but not in CFM. Although the boy showed craniofacial abnormalities and developmental delay that overlapped with Verheij syndrome, the facial asymmetry with unilateral hypoplasia of the mandible observed in this case did not match the previously reported phenotypes of PUF60 variants. Our findings expand the phenotypic range of PUF60 variants that cover CFM and Verheij syndrome.


  • Monodactyly in a patient with CHARGE syndrome: An additional case report

    by Henrique Regonaschi Serigatto, Roseli Maria Zechi‐Ceide, Isabella Parizotto, Nancy Mizue Kokitsu‐Nakata

    CHARGE syndrome is a rare autosomal dominant syndrome characterized by multiple congenital anomalies including coloboma, heart defects, ear anomalies, and developmental delay, caused by pathogenic variants in the CHD7 gene. The discovery of the molecular basis of this syndrome increased the number of cases reported and expanded the phenotype and clinical variability. Limb anomalies are occasional clinical findings in this syndrome, present in about 30% of reported cases. The occurrence of limb anomalies in this syndrome suggests that it should be considered as part of the phenotypic spectrum. Here, we describe an individual with CHARGE syndrome presenting unilateral monodactyly.

  • Mandibulofacial dysostosis Bauru type: Refining the phenotype

    by Priscila P. Moura, Nancy M. Kokitsu‐Nakata, Marília S. Yatabe, Siulan Vendramini‐Pittoli, Pedro H. Hori, Maria L. Guion‐Almeida, Daniela G. Garib, Antonio Richieri‐Costa, Roseli M. Zechi‐Ceide

    Mandibulofacial dysostosis (MFD) Bauru type (OMIM 604830) is a rare genetic condition characterized mainly by malar hypoplasia, orofacial cleft, and micrognathia. Here, we describe the clinical and radiographic sings of 13 individuals (12 female and 1 male) from eight unrelated kindreds with MFD Bauru type, including four previously reported cases, treated at the Hospital for Rehabilitation of Craniofacial Anomalies. The clinical phenotype was characterized by severe underdevelopment of mandible, midface hypoplasia, orofacial cleft, bitemporal narrowing, mild upper eyelid down slanting, high nasal bridge, thick and everted lower lip, minor ears abnormalities, and hearing loss. Radiographic aspects included downslanting of zygomatic arch, maxillary hypoplasia, microretrognathia, hypoplastic mandibular condyles, and ectopic external auditory canal. Recurrence was observed in two of eight families and the affected distribution pattern was compatible with autosomal dominant inheritance in one and autosomal recessive in another, indicating possible genetic heterogeneity for this condition. Clinical and radiographic findings in this report contribute to the delineation of this rare MFD.

  • Targeted molecular investigation in patients within the clinical spectrum of Auriculocondylar syndrome

    by Vanessa L. Romanelli Tavares, Roseli M. Zechi‐Ceide, Debora R. Bertola, Christopher T. Gordon, Simone G. Ferreira, Gabriella S. P. Hsia, Guilherme L. Yamamoto, Suzana A. M. Ezquina, Nancy M. Kokitsu‐Nakata, Siulan Vendramini‐Pittoli, et al.

    Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question mark ears, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature. So far, pathogenic variants in PLCB4, GNAI3, and EDN1 have been associated with this syndrome. It is caused by a developmental abnormality of the first and second pharyngeal arches and it is associated with great inter‐ and intra‐familial clinical variability, with some patients not presenting the typical phenotype of the syndrome. Moreover, only a few patients of each molecular subtype of Auriculocondylar syndrome have been reported and sequenced. Therefore, the spectrum of clinical and genetic variability is still not defined. In order to address these questions, we searched for alterations in PLCB4, GNAI3, and EDN1 in patients with typical Auriculocondylar syndrome (n = 3), Pierre Robin sequence‐plus (n = 3), micrognathia with additional craniofacial malformations (n = 4), or non‐specific auricular dysplasia (n = 1), which could represent subtypes of Auriculocondylar syndrome. We found novel pathogenic variants in PLCB4 only in two of three index patients with typical Auriculocondylar syndrome. We also performed a detailed comparative analysis of the patients presented in this study with those previously published, which showed that the pattern of auricular abnormality and full cheeks were associated with molecularly characterized individuals with Auriculocondylar syndrome. Finally, our data contribute to a better definition of a set of parameters for clinical classification that may be used as a guidance for geneticists ordering molecular testing for Auriculocondylar syndrome.


  • Open Access

    Interstitial 1q21.1 Microdeletion Is Associated with Severe Skeletal Anomalies, Dysmorphic Face and Moderate Intellectual Disability

    by Bruno F. Gamba, Roseli M. Zechi-Ceide, Nancy M. Kokitsu-Nakata, Siulan Vendramini-Pittoli, Carla Rosenberg, Ana C.V. Krepischi Santos, Lucilene Ribeiro-Bicudo, Antonio Richieri-Costa

    We report on a Brazilian patient with a 1.7-Mb interstitial microdeletion in chromosome 1q21.1. The phenotypic characteristics include microcephaly, a peculiar facial gestalt, cleft lip/palate, and multiple skeletal anomalies represented by malformed phalanges, scoliosis, abnormal modeling of vertebral bodies, hip dislocation, abnormal acetabula, feet anomalies, and delayed neuropsychological development. Deletions reported in this region are clinically heterogeneous, ranging from subtle phenotypic manifestations to severe congenital heart defects and/or neurodevelopmental findings. A few genes within the deleted region are associated with congenital anomalies, mainly the RBM8A, DUF1220, and HYDIN2 paralogs. Our patient presents with a spectrum of unusual malformations of 1q21.1 deletion syndrome not reported up to date.


  • Multisystem Involvement in a Patient with a PTCH1 Mutation: Clinical and Imaging Findings

    by Siulan Vendramini-Pittoli, Nancy Mizue Kokitsu-Nakata, Roseli Maria Zechi-Ceide, Camila Wenceslau Alvarez, Lucilene Arilho Ribeiro-Bicudo, Antonio Richieri-Costa

    In this article, we report on a Brazilian female patient born to consanguineous parents and presenting with alobar holoprosencephaly, severe eye involvement, and unusual skin hyperpigmented lesions. She was found to have a mutation (c.2240T > C; p.Val751Gly) in exon 15 of the PTCH1 gene. Mutations in this gene are associated with the nevoid basal cell carcinoma syndrome (NBCCS, OMIM 109400) and, in other instances, with holoprosencephaly (holoprosencephaly-7, OMIM 610828). Severe eye involvement ranging from orbital coloboma to microphthalmia has been seldom reported in patients with NBCCS with PTCH1 mutations. To our knowledge, this is the first report of an individual with central nervous system, skin, and eye manifestations due to a PTCH1 mutation. Mechanisms involved in these multisystem manifestations are discussed.